Seher Erdogan


Objective: To determine the relationship between serum uric acid level and prognosis of patients admitted to pediatric intensive care unit (PICU).
Methods: Patients admitted to pediatric intensive care unit between January 2017 and January 2018 were enrolled. Sex, age, body weight,
diagnosis, Pediatric Risk of Mortality (PRISM) score, mechanical ventilator (MV) need, number of days of mechanical ventilator, prognosis,
presence of sepsis, admission serum uric acid and creatinine levels were recorded.
Results: This study included a total of 116 patients. Of the patients, 53.4% were provided respiratory support with mechanical ventilator. 15.5% of
them died. There was a signicant correlation between serum uric acid level and PRISM score (p:0.000; p<0.05). There was no signicant
correlation between mean serum uric acid level and the duration of intensive care unit stay, prognosis, and the number of days on MV (p>0.05). The
mortality rate was 11.4% among patients who had a uric acid level between 2.6 and 7 mg/dL, while the mortality reached 50% among those with a
uric acid level above 7 mg/dL (p:0.016; p<0.05). Patients with sepsis had a serum uric acid level that was signicantly higher than those without
sepsis (4.6±2.8 vs 3.51±1.7; p:0.014).
Conclusion: serum uric acid level at PICU admission is not a suitable marker for mortality. However, it may play a role as an additional risk factor
among patients with sepsis and a uric acid level ≥7 mg/dL.


hypoperfusion prooxidant tubular reabsorption

Full Text:



Amaro S, Soy D, Obach V, Cerverea A, Planas AM, Chamorro A. A pilot study of dual treatment with recombinant tissue plasminogen activator and uric acid in acute ischemic stroke. Stroke 2007;38:2173-5.

Dawson J, Quinn T, Lees K, Walters M. The continued Yin and Yang of uric acid stroke. Stroke 2008;39:e9.

Hooman N, Mehrazma M, Nakhaii S, Otukesh H, Moradi-Lakeh M, Dianati-Maleki N, et al. The value of serum uric asid as a mortality prediction in critically ill children. Iran J Pediatr 2010; 20:323-9.

Nariman S, Mosayebi Z, Sagheb S, Rastad H, Hosseininodeh SS. Urinary uric asid/creatinine ratio as a marker of mortality and unfavorable outcome in NICU-admitted neonates.

Molinos NC, Rey GC, Medina VA, Concha TA, Menendez CS. Uric asid as a prognostic marker in critically ill patients. An Esp Pediatr 2001;55:305-9.

Webb R, Jeffries M, Sawalha AH. Uric asid promotes human T-cell activation. Am J Med Sci 2009;337:23-7.

Kang DH, Park Sk, Lee IK, Johnson RJ. Uric asid-induced C-reactive protein expression:implication on cell proliferation and nitric oxide production in human vascular cells. J Am Soc Nephrol 2005;16:3553-62.

Lapsia V, Johnson RJ, Dass B, Shimada M, Kambhampati G, Ejaz NI, et al. Elevated uric asid increases the risk for acute kidney ınjury. Am J Med 2012;125,302.e9-302.e17.

Ejaz AA, Beaver TM, Shimada M, Sood P, Lingegowda V, Schold JD, et al.Uric asid: a novel risk factor for acute kidney injury in high-risk cardiac surgery patients? Am J Nephrol 2009;30:425-9.

Nouri-Majalan N, Ardakani EF, Forouzanni K, Moshtaghian H. Effects of allopurinol and vitamin E on renal fonction in patients with cardiac coronary artery bypass grafts. Vasc Health Risk Manag 2009;5:489-94.

Ogino K, Kato M, Furuse Y, et al. Uric asid-lowering treatment with benzbromarone in patients with heart failure: a double-blind placebo-controlled crossover preliminary study. Circ Heart Fail 2010;3:73-81.

Edwards NL. The role of hyperuricemia in vascular disorders. Curr Opin Rheumatol 2009;21:132-7.

Hozawa A, Folsom AR, Ibrahim H, Javier Nieto F, Rosamond WD, Shahar E. Serum uric acid and risk of ischemic stroke: the ARIC Study. Atherosclerosis 2006;187(2):401-7.

Kim SY, Guevara JP, Kim KM,Choi HK, Heijan DF, Albert DA. Hyperuricemia and risk of stroke: a systematic review and meta-analysis. Arthritis Rheum 2009;61(7):885-92.

Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med 2008; 359: 1811


  • There are currently no refbacks.